메뉴 건너뛰기




Volumn 128, Issue 6, 2008, Pages 666-669

Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis

Author keywords

Airway; Inflammation; Plasma exudation; Rhinitis

Indexed keywords

ALLERGEN; ALPHA 2 MACROGLOBULIN; GLYCEROL OLEATE; LIPID; MACROGOL 400; PLACEBO; POLYSORBATE 80; PROPYLENE GLYCOL; SESAME SEED OIL; SODIUM CHLORIDE;

EID: 45849086933     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701642197     Document Type: Article
Times cited : (19)

References (16)
  • 1
    • 0036828311 scopus 로고    scopus 로고
    • The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study
    • Linneberg A, Henrik-Nielsen N, Frølund L, Madsen F, Dirksen A, Jørgensen T. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002;57:1048-52.
    • (2002) Allergy , vol.57 , pp. 1048-1052
    • Linneberg, A.1    Henrik-Nielsen, N.2    Frølund, L.3    Madsen, F.4    Dirksen, A.5    Jørgensen, T.6
  • 2
    • 0037957304 scopus 로고    scopus 로고
    • Requirements for medication commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA)
    • Bousquet J, Van Cauwenberger P, Bachert C, Canonica GW, Demoly P, Durham SR, et al. Requirements for medication commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 2003;58:192-7.
    • (2003) Allergy , vol.58 , pp. 192-197
    • Bousquet, J.1    Van Cauwenberger, P.2    Bachert, C.3    Canonica, G.W.4    Demoly, P.5    Durham, S.R.6
  • 3
    • 0028990176 scopus 로고
    • The leukotriene D4-receptor antagonist, ICI 204, 219, relieves symptoms of acute seasonal allergic rhinitis
    • Donnelly AL, Glass M, Minkwitz MC, Casale TB. The leukotriene D4-receptor antagonist, ICI 204, 219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995;151:1734-9.
    • (1995) Am J Respir Crit Care Med , vol.151 , pp. 1734-1739
    • Donnelly, A.L.1    Glass, M.2    Minkwitz, M.C.3    Casale, T.B.4
  • 4
    • 0035888753 scopus 로고    scopus 로고
    • Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis
    • Casale TB. Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis. Am J Respir Crit Care Med 2001;164:S18-21.
    • (2001) Am J Respir Crit Care Med , vol.164
    • Casale, T.B.1
  • 6
    • 0002956142 scopus 로고    scopus 로고
    • Nasal secretions/ exudations: Collection and approaches to analysis
    • Rodgers D, Donnelly L, editors, Totowa: Humana Press
    • Greiff L, Andersson M, Persson CGA. Nasal secretions/ exudations: collection and approaches to analysis. In: Rodgers D, Donnelly L, editors. Methods in molecular medicine. Totowa: Humana Press, 2001:61-73.
    • (2001) Methods in molecular medicine , pp. 61-73
    • Greiff, L.1    Andersson, M.2    Persson, C.G.A.3
  • 7
    • 0035016912 scopus 로고    scopus 로고
    • Grass pollen immunotherapy: Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season
    • Wilson DR, Nouri-Aia KT, Walker SM, Pajno GB, O'Brien F, Jacobson MR, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001;107:971-6.
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 971-976
    • Wilson, D.R.1    Nouri-Aia, K.T.2    Walker, S.M.3    Pajno, G.B.4    O'Brien, F.5    Jacobson, M.R.6
  • 8
    • 45849125592 scopus 로고    scopus 로고
    • Allergic rhinitis: clinical development programs for drug products. In: Guidance for the industry. Department of Health and Human Services Food and Drug Administration Centre for Drug Evaluation and Research (CDER), 2000 April. Available from: http:/www.fda.gov/cder/guidance/2718dtf.htm
    • Allergic rhinitis: clinical development programs for drug products. In: Guidance for the industry. Department of Health and Human Services Food and Drug Administration Centre for Drug Evaluation and Research (CDER), 2000 April. Available from: http:/www.fda.gov/cder/guidance/2718dtf.htm
  • 9
    • 0029070965 scopus 로고
    • Loratadine reduces allergen-induced mucosal output of a2-macroglobulin and tryptase in allergic rhinitis
    • Greiff L, Persson CGA, Svensson C, Enander I, Andersson M. Loratadine reduces allergen-induced mucosal output of a2-macroglobulin and tryptase in allergic rhinitis. J Allergy Clin Immunol 1995;96:97-103.
    • (1995) J Allergy Clin Immunol , vol.96 , pp. 97-103
    • Greiff, L.1    Persson, C.G.A.2    Svensson, C.3    Enander, I.4    Andersson, M.5
  • 11
    • 45849118892 scopus 로고    scopus 로고
    • The European Pharmacopoeia, 5th edn. Available from: http:/www.edqm.eu/ site/page_581.php
    • The European Pharmacopoeia, 5th edn. Available from: http:/www.edqm.eu/ site/page_581.php
  • 12
    • 0033709747 scopus 로고    scopus 로고
    • Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5
    • Linden M, Svensson C, Andersson E, Andersson M, Greiff L, Persson CGA. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5. Am J Respir Crit Care Med 2000;162:1705-8.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 1705-1708
    • Linden, M.1    Svensson, C.2    Andersson, E.3    Andersson, M.4    Greiff, L.5    Persson, C.G.A.6
  • 14
    • 27744435373 scopus 로고    scopus 로고
    • Lipid pneumonia due to Mexican folk remedies. Arch Pediatr Adolesc Med 2005;149:1043-8.
    • Lipid pneumonia due to Mexican folk remedies. Arch Pediatr Adolesc Med 2005;149:1043-8.
  • 15
    • 0032560126 scopus 로고    scopus 로고
    • Lipids are required for directional pollen-tube growth
    • Wolters-Arts M, Lush WM, Mariani C. Lipids are required for directional pollen-tube growth. Nature 1998;392:818-21.
    • (1998) Nature , vol.392 , pp. 818-821
    • Wolters-Arts, M.1    Lush, W.M.2    Mariani, C.3
  • 16
    • 0033975173 scopus 로고    scopus 로고
    • A simple advice for the prevention of pollen-induced allergic rhinitis
    • Bufe A. A simple advice for the prevention of pollen-induced allergic rhinitis. Int Arch Allergy Immunol 2000;121:85-6.
    • (2000) Int Arch Allergy Immunol , vol.121 , pp. 85-86
    • Bufe, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.